Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.2M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
1.01M
-
Shares change
-
+927K
-
Total reported value, excl. options
-
$12.8M
-
Value change
-
+$12.7M
-
Number of buys
-
22
-
Number of sells
-
-1
-
Price
-
$12.67
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q3 2016
25 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock as of Q3 2016.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.01M shares
of 22.2M outstanding shares and own 4.54% of the company stock.
Largest 10 shareholders include CAXTON CORP (507K shares), ARMISTICE CAPITAL, LLC (132K shares), VANGUARD GROUP INC (102K shares), Rock Springs Capital Management LP (63K shares), BAKER BROS. ADVISORS LP (57.8K shares), RENAISSANCE TECHNOLOGIES LLC (53K shares), CITADEL ADVISORS LLC (26.2K shares), GEODE CAPITAL MANAGEMENT, LLC (18.3K shares), MILLENNIUM MANAGEMENT LLC (16.2K shares), and GOLDMAN SACHS GROUP INC (12K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.